|
|
| Catalog Number |
UNK HARMONYCA LIDO |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Hernia (2240)
|
| Date of Event |
03/26/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Continued d.10.Concomitant therapies: amlodipine, furoate, mometasone, citalopram, betaderm, and irbesartan.Continued h.6.Health effect - impact codes: f2303 clarification to h.6.Type of investigation code: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.The event is a physiological complication and analysis of the device generally does not assist abbvie in determining a probable cause for this event.The event of hernia, deemed not device related is considered an unexpected adverse drug experience.
|
| |
|
Event or Problem Description
|
|
Healthcare professional (hcp) reported a clinical patient was injected in the cheeks bilaterally with 2.3ml of harmonyca lidocaine.About one month later the patient received touch-up injections with 1.1ml of harmonyca lidocaine.The patient was concomitantly treated with topical pre-treatment anesthesia and concomitantly takes amlodipine, furoate, mometasone, citalopram, betaderm, and irbesartan.Approximately seven months and a half after the touch-up injections the patient experienced non device related ¿hernia¿.About three weeks later, patient was hospitalized and underwent a hernia surgery.Patient was also treated with hydromorphone.The event resolved the same day.This is the same event and the same patient reported under mdr id# 3005113652-2024-0011046 (abbvie complaint # (b)(4).This mdr is being submitted for the first injection.
|
| |
|
Search Alerts/Recalls
|
|
|